Cannabidiol in inflammatory bowel diseases: a brief overview

 

Cannabis finds its way into treatment of Crohn’s disease

 

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

 

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

 

The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis

 

Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice

 

Cannabinoids and the gut: New developments and emerging concepts

 

Endocannabinoids and the gastrointestinal tract

 

Cannabinoids and gastrointestinal motility: Animal and human studies

 

Hergenrather presents study of Crohn’s patients as a template for clinical research on Cannabis